Phenformin

What is Phenformin?

Phenformin is a synthetic oral antidiabetic drug belonging to the biguanide class. Historically, it was prescribed for the management of type 2 diabetes mellitus, particularly in the mid-20th century. While once a significant treatment option, Phenformin was largely withdrawn from markets worldwide due to its association with a high risk of a severe and often fatal metabolic complication known as lactic acidosis. It shares its chemical class with metformin, another biguanide, but their safety profiles differ significantly, leading to Phenformin's discontinuation in most regions.

How Does it Work?

Phenformin's mechanism of action is characteristic of the biguanide class, focusing on lowering blood glucose levels through several key pathways without directly stimulating insulin secretion. Its primary actions include:

• Reduction of Hepatic Glucose Production: Phenformin decreases the liver's output of glucose by inhibiting gluconeogenesis (the synthesis of glucose from non-carbohydrate sources) and glycogenolysis (the breakdown of glycogen into glucose).
• Increased Peripheral Glucose Uptake: It enhances the uptake and utilization of glucose by peripheral tissues, such as muscle and fat cells, thereby improving insulin sensitivity. This makes the body's own insulin more effective.
• Decreased Intestinal Glucose Absorption: Phenformin also reduces the absorption of glucose from the gastrointestinal tract, contributing to lower post-meal blood sugar spikes.

Unlike sulfonylureas, Phenformin does not increase insulin release from the pancreatic beta cells, which means it rarely causes hypoglycemia (low blood sugar) when used as monotherapy.

Medical Uses

The sole approved medical use for Phenformin was in the treatment of type 2 diabetes mellitus. It was primarily indicated for patients whose blood sugar could not be adequately controlled through diet and exercise alone, especially those who were overweight or obese. Its ability to lower blood glucose without causing weight gain (and sometimes even promoting modest weight loss) made it an attractive option. However, due to the severe safety concerns, particularly the high incidence of lactic acidosis, its use for diabetes management ceased in most countries decades ago. Today, it is not considered a viable or safe treatment option for diabetes.

Dosage

As Phenformin has been withdrawn from most pharmaceutical markets due to safety concerns, current dosage recommendations are not applicable. Historically, when it was in use, Phenformin was typically administered orally. The dosage was individualized based on the patient's response and tolerance, usually starting with a low dose and gradually increasing. Common historical dosages ranged from 25 mg to 150 mg per day, often divided into two or three doses taken with meals. However, it is critical to reiterate that this information is for historical reference only and should not be used for prescribing or self-medication.

Side Effects

The most significant and dangerous side effect associated with Phenformin, which ultimately led to its withdrawal, is lactic acidosis. This is a life-threatening metabolic emergency characterized by an excessive accumulation of lactic acid in the blood, leading to severe acid-base imbalance. Symptoms can include malaise, myalgia (muscle pain), respiratory distress, somnolence, and abdominal distress. Risk factors for lactic acidosis with Phenformin included renal impairment, liver disease, heart failure, acute illness, and concurrent alcohol consumption.

Other, more common but less severe, side effects included:

• Gastrointestinal disturbances: nausea, vomiting, diarrhea, abdominal pain, and a metallic taste in the mouth.
• Anorexia (loss of appetite).

The incidence of lactic acidosis with Phenformin was notably higher and more severe compared to its counterpart, metformin, which remains a cornerstone of type 2 diabetes treatment with a much lower risk profile when used appropriately.

Drug Interactions

When Phenformin was in use, several drug interactions were identified that could impact its efficacy or increase the risk of adverse effects, particularly lactic acidosis:

• Alcohol: Concomitant use of alcohol significantly increased the risk of lactic acidosis.
• Cimetidine: Could increase the plasma concentration of biguanides, potentially enhancing their effects and side effects.
• Iodinated Contrast Agents: Administration of iodinated contrast agents for imaging procedures could lead to acute kidney injury, thereby increasing the risk of lactic acidosis in patients taking Phenformin.
• Diuretics (e.g., Thiazides, Loop Diuretics): Certain diuretics could affect renal function or impact blood glucose levels, requiring careful monitoring.
• Corticosteroids, Sympathomimetics, Phenothiazines: These drugs could increase blood glucose levels, potentially necessitating an adjustment in Phenformin dosage if it were still prescribed.

FAQ

Is Phenformin still prescribed today?

No, Phenformin has been withdrawn from most pharmaceutical markets globally due to its significant and often fatal risk of lactic acidosis. It is not considered a safe or effective treatment option for diabetes today.

Why was Phenformin withdrawn?

It was primarily withdrawn because of its strong association with a high incidence of severe lactic acidosis, a life-threatening metabolic complication. The benefits were deemed to no longer outweigh the substantial risks.

What are the alternatives to Phenformin for type 2 diabetes?

The most common and safer alternative from the biguanide class is metformin. Other modern treatment options for type 2 diabetes include sulfonylureas, GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, and insulin, among others.

How does Phenformin compare to Metformin?

Both are biguanide drugs that lower blood glucose, but Phenformin carries a significantly higher risk of lactic acidosis compared to metformin. Metformin is generally safe and effective when used appropriately and is a first-line therapy for type 2 diabetes, while Phenformin was withdrawn due to its poor safety profile.

Can Phenformin cause weight loss?

Like some other antidiabetic medications, Phenformin could lead to modest weight loss or be weight-neutral. However, any potential weight benefit was far outweighed by the severe risk of lactic acidosis, making it an unacceptable treatment option.

Products containing Phenformin are available through trusted online pharmacies. You can browse Phenformin-based medications at ShipperVIP or Medicenter.

Summary

Phenformin was an early oral biguanide antidiabetic drug used to manage type 2 diabetes. While it demonstrated efficacy in lowering blood glucose levels through mechanisms similar to metformin, its widespread use was curtailed due to a critical safety concern: a high incidence of severe and often fatal lactic acidosis. This significant risk led to its withdrawal from most global markets, marking a pivotal moment in pharmaceutical regulation and patient safety. Today, safer and more effective alternatives, such as metformin and a range of newer antidiabetic agents, are available, underscoring the importance of continuous evaluation of drug safety and efficacy in modern medicine.